What is a stock summary page? Click here for an overview.
Business Description
3D Global Biotech Inc
ISIN : TW0006808009
Share Class Description:
ROCO:6808: Ordinary SharesDescription
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 47.95 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.92 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 75.43 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.2 | |||||
| 3-Year EBITDA Growth Rate | -12.5 | |||||
| 3-Year EPS without NRI Growth Rate | -5 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | -14.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.44 | |||||
| 9-Day RSI | 40.1 | |||||
| 14-Day RSI | 40.9 | |||||
| 3-1 Month Momentum % | -6.16 | |||||
| 6-1 Month Momentum % | 45.66 | |||||
| 12-1 Month Momentum % | 77.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.79 | |||||
| Quick Ratio | 6.05 | |||||
| Cash Ratio | 5.93 | |||||
| Days Inventory | 304.9 | |||||
| Days Sales Outstanding | 14.9 | |||||
| Days Payable | 268.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -4.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.12 | |||||
| Operating Margin % | -63.51 | |||||
| Net Margin % | -53.32 | |||||
| FCF Margin % | -24.76 | |||||
| ROE % | -8.3 | |||||
| ROA % | -7.47 | |||||
| ROIC % | -22.39 | |||||
| 3-Year ROIIC % | 27.54 | |||||
| ROC (Joel Greenblatt) % | -215.04 | |||||
| ROCE % | -8.44 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 57.45 | |||||
| PB Ratio | 7.47 | |||||
| Price-to-Tangible-Book | 9.44 | |||||
| EV-to-EBIT | -107.75 | |||||
| EV-to-EBITDA | -421.81 | |||||
| EV-to-Revenue | 59.11 | |||||
| EV-to-FCF | -262.35 | |||||
| Price-to-GF-Value | 0.88 | |||||
| Price-to-Net-Current-Asset-Value | 10.29 | |||||
| Price-to-Net-Cash | 12.08 | |||||
| Earnings Yield (Greenblatt) % | -0.92 | |||||
| FCF Yield % | -0.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3D Global Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 55.15 | ||
| EPS (TTM) (NT$) | -0.514 | ||
| Beta | 0.34 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 1.15 | ||
| Volatility % | 47.59 | ||
| 14-Day RSI | 40.9 | ||
| 14-Day ATR (NT$) | 4.128502 | ||
| 20-Day SMA (NT$) | 57.8975 | ||
| 12-1 Month Momentum % | 77.46 | ||
| 52-Week Range (NT$) | 29.369124 - 73.5 | ||
| Shares Outstanding (Mil) | 76.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3D Global Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3D Global Biotech Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
3D Global Biotech Inc Frequently Asked Questions
What is 3D Global Biotech Inc(ROCO:6808)'s stock price today?
The current price of ROCO:6808 is NT$50.50. The 52 week high of ROCO:6808 is NT$73.50 and 52 week low is NT$29.37.
When is next earnings date of 3D Global Biotech Inc(ROCO:6808)?
The next earnings date of 3D Global Biotech Inc(ROCO:6808) is .
Does 3D Global Biotech Inc(ROCO:6808) pay dividends? If so, how much?
3D Global Biotech Inc(ROCO:6808) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers